138 related articles for article (PubMed ID: 38704941)
21. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury.
Zhao LX; Liu AC; Yu SW; Wang ZX; Lin XQ; Zhai GX; Zhang QZ
Biol Pharm Bull; 2013; 36(8):1263-70. PubMed ID: 23902970
[TBL] [Abstract][Full Text] [Related]
22. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.
Gupta SV; Gupta D; Sun J; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
Mol Pharm; 2011 Dec; 8(6):2358-67. PubMed ID: 21905667
[TBL] [Abstract][Full Text] [Related]
23. Is prodrug design an approach to increase water solubility?
Sanches BMA; Ferreira EI
Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
[TBL] [Abstract][Full Text] [Related]
24. Magnesium sulfate protects blood-brain barrier integrity and reduces brain edema after acute ischemic stroke in rats.
Shadman J; Sadeghian N; Moradi A; Bohlooli S; Panahpour H
Metab Brain Dis; 2019 Aug; 34(4):1221-1229. PubMed ID: 31037556
[TBL] [Abstract][Full Text] [Related]
25. Xanthotoxol exerts neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia.
He W; Chen W; Zhou Y; Tian Y; Liao F
Cell Mol Neurobiol; 2013 Jul; 33(5):715-22. PubMed ID: 23619720
[TBL] [Abstract][Full Text] [Related]
26. Progress in drug delivery to the central nervous system by the prodrug approach.
Pavan B; Dalpiaz A; Ciliberti N; Biondi C; Manfredini S; Vertuani S
Molecules; 2008 May; 13(5):1035-65. PubMed ID: 18560328
[TBL] [Abstract][Full Text] [Related]
27. [Effects of aromatic resuscitation drugs on blood brain barrier in cerebral ischemia-reperfusion injury model rats].
Ni C; Zeng N; Xu F; Gou L; Liu J; Wang J; Xia H
Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(18):2562-6. PubMed ID: 22256767
[TBL] [Abstract][Full Text] [Related]
28. Buyang Huanwu Decoction Attenuates Infiltration of Natural Killer Cells and Protects Against Ischemic Brain Injury.
Dou B; Zhou W; Li S; Wang L; Wu X; Li Y; Guan H; Wang C; Zhu S; Ke Z; Huang C; Wang Z
Cell Physiol Biochem; 2018; 50(4):1286-1300. PubMed ID: 30355926
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine.
Peura L; Malmioja K; Huttunen K; Leppänen J; Hämäläinen M; Forsberg MM; Gynther M; Rautio J; Laine K
Pharm Res; 2013 Oct; 30(10):2523-37. PubMed ID: 24137801
[TBL] [Abstract][Full Text] [Related]
30. Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats.
Meng F; Liu R; Gao M; Wang Y; Yu X; Xuan Z; Sun J; Yang F; Wu C; Du G
Brain Res; 2011 May; 1391():93-101. PubMed ID: 21435338
[TBL] [Abstract][Full Text] [Related]
31. The protective role of Tongxinluo on blood-brain barrier after ischemia-reperfusion brain injury.
Liu Y; Tang GH; Sun YH; Lin XJ; Wei C; Yang GY; Liu JR
J Ethnopharmacol; 2013 Jul; 148(2):632-9. PubMed ID: 23707212
[TBL] [Abstract][Full Text] [Related]
32. Amino Acids in the Development of Prodrugs.
Vale N; Ferreira A; Matos J; Fresco P; Gouveia MJ
Molecules; 2018 Sep; 23(9):. PubMed ID: 30208629
[TBL] [Abstract][Full Text] [Related]
33. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4.
Chu H; Yang X; Huang C; Gao Z; Tang Y; Dong Q
Cerebrovasc Dis; 2017; 44(1-2):10-25. PubMed ID: 28402976
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets.
Puris E; Gynther M; de Lange ECM; Auriola S; Hammarlund-Udenaes M; Huttunen KM; Loryan I
Mol Pharm; 2019 Jul; 16(7):3261-3274. PubMed ID: 31180686
[TBL] [Abstract][Full Text] [Related]
35. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
36. Permeability changes in response to NONOate and NONOate prodrug derived nitric oxide in a blood-brain barrier model formed by primary porcine endothelial cells.
Winter S; Konter J; Scheler S; Lehmann J; Fahr A
Nitric Oxide; 2008 May; 18(3):229-39. PubMed ID: 18284923
[TBL] [Abstract][Full Text] [Related]
37. Cyclization-activated prodrugs.
Gomes P; Vale N; Moreira R
Molecules; 2007 Nov; 12(11):2484-506. PubMed ID: 18065953
[TBL] [Abstract][Full Text] [Related]
38. Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions.
Kikuchi T; Fukuta T; Agato Y; Yanagida Y; Ishii T; Koide H; Shimizu K; Oku N; Asai T
J Pharm Sci; 2019 Dec; 108(12):3823-3830. PubMed ID: 31520645
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
40. Nanomedicinal Strategies as Emerging Therapeutic Avenues to Treat and Manage Cerebral Ischemia.
Fatima S; Quadri SN; Parveen S; Beg S; Barkat MA; Samim M; Abdin MZ; Ahmad FJ
CNS Neurol Disord Drug Targets; 2021; 20(2):125-144. PubMed ID: 33138766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
